5:12 PM
 | 
Mar 28, 2013
 |  BC Extra  |  Company News

Janssen submits simeprevir NDA

The Janssen Research & Development LLC unit of Johnson & Johnson (NYSE:JNJ) submitted an NDA to FDA for simeprevir (...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >